Literature DB >> 27909791

Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.

Mohammad Taghi Rahimi1,2, Shahabeddin Sarvi2,3, Mahdi Sharif2,3, Saeid Abediankenari4, Ehsan Ahmadpour5, Reza Valadan4,6, Mahdi Fasihi- Ramandie7, Seyed-Abdollah Hosseini2,8, Ahmad Daryani9,10.   

Abstract

Many recent studies have been conducted to evaluate protective immunity mediated by DNA vaccines against toxoplasmosis. Cocktail DNA vaccines showed better immune responses compared to single vaccines. The objective of the current study was to evaluate the protective efficacy of rhomboid 4 (ROM4) and cocktail DNA vaccines (ROM4 + GRA14) of the Toxoplasma gondii RH strain with or without coated calcium phosphate nanoparticles (CaPNs) as the adjuvant to improve the immunogenicity against the T. gondii RH strain in BALB/c mice. Cocktail DNA vaccines of pcROM4 + pcGRA14 of the T. gondii RH strain were constructed. CaPNs were synthesized and the cocktail DNA vaccine was coated with the adjuvant of CaPNs. Immunogenicity and the protective effects of cocktail DNA vaccines with or without CaPNs against lethal challenge were evaluated in BALB/c mice. pcROM4 and cocktail DNA vaccine coated with CaPNs significantly enhanced cellular and humoral immune responses against Toxoplasma compared to pcROM4 and cocktail DNA vaccine without CaPNs (p < 0.05). These findings indicate that the survival time of immunized mice after challenge with the RH strain of T. gondii was increased compared to that of controls and the DNA vaccine provided significant protection in mice (p < 0.05). The CaPN-based cocktail DNA vaccine of pcROM4 + pcGRA14 showed the longest survival time compared to the other groups. Co-immunization with CaPN-based cocktail DNA vaccine (pcROM4 + pcGRA14) boosted immune responses and increased the protective efficacy against acute toxoplasmosis in BALB/c mice compared to both single gene and bivalent DNA vaccine without nano-adjuvants.

Entities:  

Keywords:  Adjuvant; DNA vaccine; Dense granule 14; Immune response; Rhomboid 4; Toxoplasma gondii

Mesh:

Substances:

Year:  2016        PMID: 27909791     DOI: 10.1007/s00436-016-5325-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  33 in total

Review 1.  Nanoparticle vaccines.

Authors:  Liang Zhao; Arjun Seth; Nani Wibowo; Chun-Xia Zhao; Neena Mitter; Chengzhong Yu; Anton P J Middelberg
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

2.  Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii.

Authors:  Hai-Kuo Yan; Zi-Guo Yuan; Hui-Qun Song; Eskild Petersen; Yang Zhou; Di Ren; Dong-Hui Zhou; Hao-Xin Li; Rui-Qing Lin; Gui-Lian Yang; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

Review 3.  Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients.

Authors:  Vera Lucia Pereira-Chioccola; José Ernesto Vidal; Chunlei Su
Journal:  Future Microbiol       Date:  2009-12       Impact factor: 3.165

Review 4.  Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention.

Authors:  Stacey A Elmore; Jeffrey L Jones; Patricia A Conrad; Sharon Patton; David S Lindsay; J P Dubey
Journal:  Trends Parasitol       Date:  2010-03-02

5.  Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice.

Authors:  Alberto Fachado; Alexandro Rodriguez; Sergio O Angel; Diamar C Pinto; Iviane Vila; Armando Acosta; Regina R Amendoeira; Joseli Lannes-Vieira
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

Review 6.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

7.  Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant.

Authors:  D Buxton; K Thomson; S Maley; S Wright; H J Bos
Journal:  Vet Rec       Date:  1991-08-03       Impact factor: 2.695

8.  Functional analysis of rhomboid proteases during Toxoplasma invasion.

Authors:  Bang Shen; Jeffrey S Buguliskis; Tobie D Lee; L David Sibley
Journal:  mBio       Date:  2014-10-21       Impact factor: 7.867

Review 9.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

10.  Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?

Authors:  Joanna Matowicka-Karna; Violetta Dymicka-Piekarska; Halina Kemona
Journal:  Clin Dev Immunol       Date:  2009-05-25
View more
  6 in total

Review 1.  Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.

Authors:  João Paulo Assolini; Virginia Márcia Concato; Manoela Daiele Gonçalves; Amanda Cristina Machado Carloto; Ivete Conchon-Costa; Wander Rogério Pavanelli; Francine Nesello Melanda; Idessania Nazareth Costa
Journal:  Parasitol Res       Date:  2017-05-05       Impact factor: 2.289

Review 2.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

Review 3.  Biodegradable calcium phosphate nanoparticles for cancer therapy.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  Adv Colloid Interface Sci       Date:  2020-04-10       Impact factor: 12.984

4.  Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.

Authors:  Zohre Sadeghi; Mahdi Fasihi-Ramandi; Saeid Bouzari
Journal:  Int J Nanomedicine       Date:  2020-05-29

5.  Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen.

Authors:  Min-Ju Kim; Jie Mao; Hae-Ji Kang; Ki-Back Chu; Fu-Shi Quan
Journal:  Korean J Parasitol       Date:  2021-12-22       Impact factor: 1.341

6.  Toxoplasma gondii Dense Granule Proteins 7, 14, and 15 Are Involved in Modification and Control of the Immune Response Mediated via NF-κB Pathway.

Authors:  Fumiaki Ihara; Ragab M Fereig; Yuu Himori; Kyohko Kameyama; Kosuke Umeda; Sachi Tanaka; Rina Ikeda; Masahiro Yamamoto; Yoshifumi Nishikawa
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.